News & Events

Investor Center

Careers

Pipeline

Partnership

About  Us

About Us

Research & Development

Research & Development Pipeline Partership Investor Center News & Events Careers
Home

中文

Contact
   Home    Home-Ch
Press Releases
More Ascletis News
News & Events

Dec 11, 2016   The  Program of Eliminating HCV in Zhejiang Officially Launched >>

20161211EHCVinZH.pdf    Home-Ch
© 2016 Ascletis. All Rights Reserved
浙公网安备 33010802003344 号
CONTACT US
pr@ascletis.com
hr@ascletis.com
bd@ascletis.com
clinicaltrials@ascletis.com
Contact

Jan 03, 2017   Ascletis Raises US$100 Million in Series B Financing >>

20170103AscletisSeriesBfinancing.pdf

Nov 20, 2016   Ascletis Participated in 8th National Conference of Chronic Viral Hepatitis >>

20161120NCofCVH.pdf

Dec 06, 2016   Mayor of Shaoxing Mr. Ma Weiguang Paid a Visit to Ascletis >>

20161206MayorMaCh.pdf

Dec 27, 2016   Ascletis’ NDA for HCV Treatment  Danoprevir Accepted by CFDA  >>

20161227ASC08DNA.pdf

Feb 19, 2017   Ascletis Presented at the 26th APASL Annual Meeting and Held Successfully “China - developed DAAs”  Symposium >>

20170219APASL.pdf
CCTV Report on HCV
Partnership
APASL Panel Review
Partership APASL2015Prof.Wei.pdf

Guidelines for the HCV Treatment

GuidelinesForHCV2015.pdf

Danoprevir

HIV in China
BioDiscover Interview
Corporate Member

Ascletis is a specialty therapeutics company dedicated to discovering

and developing important new treatments for cancer and infectious diseases.

HCV IN CHINA

歌礼与您携手

共同抗击肝炎

Together, Cure Hepatitis

7.28 世界肝炎日

World Hepatitis Day